Rare diseases
Investigational molecules
Locations
278 conditions with trials, the busiest first
677 trials across Europe, recruiting first
PolandA study to evaluate the safety and effectiveness of dalbavancin in patients with erysipelas or limited cellulitis being treated at home.
AustriaUsing fludeoxyglucose (18F) in PET/CT imaging to diagnose and monitor cardiovascular device infections
SpainUsing a drug combination to treat vaginal flora abnormalities in pregnant women at high risk of preterm birth.
FranceStudy of methenamine hippurate compared to a drug combination for preventing recurrent urinary tract infections in women
SpainStudy to evaluate the efficacy and safety of liposomal amphotericin B for patients with simple pulmonary aspergilloma
LatviaSafety and efficacy of elfucose, d‑galactose and polyhexanide solution 20% in patients with chronic wounds colonized by Pseudomonas aeruginosa
GermanyComparison of amoxicillin, amoxicillin-clavulanate, and placebo for the treatment of middle ear infection in children
FinlandA study to evaluate the safety and effectiveness of MRNA3771 and GRNA1599 in adults with chronic hepatitis B
FranceA study to evaluate the effectiveness of upadacitinib and pirfenidone in reducing symptom severity in patients with Long Covid
ItalyTesting Personalized Drug Combination Treatment to Reduce Deaths in Patients with Severe Acute Infections
DenmarkStudy of Intravenous Immunoglobulin Added to Standard Treatment for COVID-19 in Patients with Severely Weakened Immune System Due to B-cell Problems
SwedenThe therapies tested most often in Infections and infestations trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
